Page 2 - Gilbert Ghostine News Today

News and information from Switzerland about Switzerland: direct democracy, education, science, business, living in Switzerland and a lot more – current, informative, in depth and in 10 languages (English, German, French, Italian, Spanish, Portuguese, Arabic, Japanese, Chinese, Russian).

Spin-off from Novartis successfully completed with first trading day today on SIX Swiss Exchange; Sandoz shares included in key market indicesStandalone...

2023 Half-Year ResultsPress release – Paris, July 26, 2023 Solid first half of the yearMaking consistent progress on Renew Danone Net sales reached €14,167m in H1 2023, up +6.3% on a reported basis and +8.4% on a like-for-like (LFL) basis, with price up +9.4%, and volume/mix down -1.1%Q2 sales growth reached +6.4% on a LFL basis, with price up +8.7% and volume/mix down -2.3% +6.5% in Europe, driven by France, Poland and Spain; further progress on EDP portfolio transformation+5.0% i...

2023 Half-Year ResultsPress release – Paris, July 26, 2023 Solid first half of the yearMaking consistent progress on Renew Danone Net sales reached...

Deal Overview On July 18, 2023, Novartis AG (NYSE: NVS, $105.01, Market Capitalization $239.2 billion), a leading global medicine company, announced that its Board of ...

Sandoz well positioned to deliver continued mid-single digit sales growth; core EBITDA margin of 24-26% and Free Cash Flow to more than double over mid...

Sandoz well positioned to deliver continued mid-single digit sales growth; core EBITDA margin of 24-26% and Free Cash Flow to more than double over mid term European champion committed to further extending

Novartis Board of Directors approves the recommendation of Sandoz Chairman-designate for the future Sandoz Board of Directors, to start preparatory work in...

Eight of the 14 advisers to the Food and Drug Administration late Friday voted that the company had enough data to support an accelerated approval for its gene therapy for Duchenne muscular dystrophy (DMD). KKR-backed Envision Healthcare files for bankruptcy KKR & Co Inc-backed Envision Healthcare Corp and its wholly owned subsidiaries filed for Chapter 11 bankruptcy protection on Monday.

Novartis announces 10 members to its newly formed Sandoz board of directors.